Science and Technology, Scrutiny, MRC, AMRC, Cancer Research UK, Wellcome Trust, ABPI, GlaxoSmithKline, lshtm
Committee takes evidence on clinical trials
22 April 2013
The Science and Technology Committee will hold the following rescheduled evidence session in its inquiry into ‘Clinical trials’:
Witnesses
Monday 22 April 2013, Committee Room 8, Palace of Westminster
At 5.15pm
- Dr Catherine Elliott, Director, Clinical Research Interests, Medical Research Council
- Sharmila Nebhrajani, Chief Executive, Association of Medical Research Charities
- Professor Peter Johnson, Chief Clinician, Cancer Research UK
- Nicola Perrin, Head of Policy, Wellcome Trust;
At 6.00pm
- Dr Bina Rawal, Director of Research, Medical and Innovation, Association of the British Pharmaceutical Industry
- Dr James Shannon, Chief Medical Officer, GlaxoSmithKline
- William M Burns, Member of the Board of Directors, Roche
- Dr Ben Goldacre, Wellcome Research Fellow in Epidemiology, London School of Hygiene and Tropical Medicine